BUZZ-Iovance falls after Q2 revenue miss, wider loss
Reuters
Aug 08
BUZZ-Iovance falls after <a href="https://laohu8.com/S/QTWO">Q2</a> revenue miss, wider loss
** Shares of drugmaker Iovance BiotherapeuticsIOVA.O fall 30.7% to $1.83 in extended trading
** Co reports Q2 revenue of $60 million, falling short of analysts' average estimate of $69.79 million, according to data compiled by LSEG
** Posts Q2 loss of 33 cents, analysts expected a loss of 28 cents
** Co says it is reducing its workforce by 19% by the third quarter of this year
** IOVA reiterates total product revenue guidance within the range of $250 million to $300 million vs est of $300.18 million
** Stock down 64.3% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.